ArticleOncogene2021

The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.

Dennis Kobelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.